Encompass Health Corp (NYSE:EHC) has received a consensus recommendation of “Buy” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $75.57.

Separately, ValuEngine raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Monday, February 4th.

EHC traded down $1.79 on Monday, reaching $59.48. The stock had a trading volume of 1,653,676 shares, compared to its average volume of 810,495. Encompass Health has a 12-month low of $56.24 and a 12-month high of $82.46. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.98 and a current ratio of 0.98. The stock has a market capitalization of $6.05 billion, a price-to-earnings ratio of 16.39, a PEG ratio of 1.58 and a beta of 0.71.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 7th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.01. The business had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Encompass Health had a net margin of 6.83% and a return on equity of 23.74%. On average, equities research analysts forecast that Encompass Health will post 3.76 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.27 per share. The ex-dividend date was Friday, March 29th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.82%. Encompass Health’s dividend payout ratio is currently 29.75%.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Article: What is the price-to-earnings growth (PEG) ratio?

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.